Revealing 2 years no HPV vaccination to prevent cervical cancer female grade 5 students from the shortage of vaccines around the world. This year’s part has been provided for 4 hundred thousand people. Ready to accelerate additional procurement to inject backwards for another 8 hundred thousand people. Effectiveness has been used for more than 10 years. High protection 90%.
On July 28, Dr. Nakhon Premsri, director of the National Vaccine Institute, said that HPV vaccines are now being procured. To be injected to prevent cervical cancer for girls in Grade 5 (Grade 5) of the year 2022, approximately 4 hundred thousand people, which is sufficient. However, during the past two years around the world there has been a shortage of HP vaccine. V partly due to the situation of COVID-19 causing insufficient supply chain Therefore, it is not imported to inject in grade 5 female students, therefore, has expedited the procurement of HPV vaccine to be injected retrospectively for approximately 8 hundred thousand female students in such groups.
Nakorn said that It is now known that China is in the process of registering additional HPV vaccines with the Food and Drug Administration (FDA), if there are more vaccines from China and India. It will help Thailand to provide more and cheaper HPV vaccines. It will increase access to the HPV vaccine. For the effectiveness of the actual use of the HPV vaccine. After approximately 10 years of follow-up, approximately 90% of cervical cancer prevention was found to be very high and reflects the longevity of the vaccine-derived immunity. But how much can it be monitored to reduce the incidence of cervical cancer? Long-term follow-up is required. This is because infection with the Human Papilloma virus (HPV) can occur over the course of a lifetime.